New DBS device for Parkinson’s approved for US patients

News

Author: AdminPublished: 24 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US Food and Drug Administration (FDA) has approved a new implantable deep brain stimulation device (DBS) called the Brio Neurostimulation System.

Previously the Activa DBS Therapy System manufactured by Medtronic was the only device available to patients in the US.

Like the Activa system, the newly approved Brio system consists of a battery-powered rechargeable electrical pulse generator that is inserted under the skin of the upper chest and wires that lead to electrodes implanted in the brain.

The new Brio system is made by St. Jude Medical.

Go Back

Share this story

Comments


Related articles


Global update

Support Parkinson’s organisations across the world on #GivingTuesday

The Big Give, the MJFF and the APDA to match-fund donations

READ MORE
Copenhagen unity walk

Europe

Denmark walks for Parkinson’s

The 4th Copenhagen Unity walk takes place at the end of May

READ MORE
unite-for-parkinsons

Global update

#UniteForParkinsons 2018: EPDA and Parkinson’s UK launch this year’s campaign

The EPDA and Parkinson's UK aiming to build on last year's success

READ MORE